OTC · REFG
Medical Cannabis Payment Solutions
$0.00$0.00 (0.0%)
Medical Cannabis Payment Solutions’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
Loading market information…
OTC · DNAG · USD
Stock price
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
DNAPrint Genomics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
DNAPrint Genomics, Inc. focuses on pioneering and distributing genetic analysis solutions and services. Their product portfolio includes AncestryByDNA, a comprehensive chromosomal assay for tracing genetic lineage, and EurasianDNA, designed to identify specific European ancestral subdivisions. They also offer EuropeanDNA, which outlines an individual's fundamental continental European heritage. In forensic science, DNAWitness assists in determining genetic background from crime scene samples, while RETINOME is utilized by detectives to construct physical traits, such as eye color, from DNA evidence or human remains. Furthermore, the company provides the GenomeLab SNPstream Genotyping System, recognized for its high genotyping throughput, multiplexing capabilities, and efficient reagent usage. DNAPrint Genomics caters to diverse clients in fields like forensic investigation, genealogical exploration, consumer products, and pharmaceutical research. Originally incorporated in 1983 as Lexington Energy, Inc., the company operates from Sarasota, Florida, with an international presence through a subsidiary in Leverkusen, Germany.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:09 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
Medical Cannabis Payment Solutions’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Jack Nathan Medical Corp.’s quoted price sits in the lower half of its reported 52-week range, 94.15% below the high.
$0.00$0.00 (0.0%)
Mobile Lads Corp.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00-$0.00 (-50.0%)
U.S. Stem Cell, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00$0.00 (0.0%)
Manhattan Scientifics, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Mera Pharmaceuticals, Inc.: Healthcare · Biotechnology.
$0.00$0.00 (0.0%)
Braxia Scientific Corp.’s quoted price sits in the lower half of its reported 52-week range, 92.19% below the high.
$0.00$0.00 (0.0%)
AVAX Technologies, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
